| 前收市價 | 9.43 |
| 開市 | 9.73 |
| 買盤 | 10.03 x 200 |
| 賣出價 | 10.13 x 100 |
| 今日波幅 | 9.72 - 10.19 |
| 52 週波幅 | 3.81 - 17.70 |
| 成交量 | |
| 平均成交量 | 292,537 |
| 市值 | 594.8M |
| Beta 值 (5 年，每月) | 0.25 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -4.71 |
| 業績公佈日 | 2024年5月10日 - 2024年5月14日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 21.22 |
ZacksIGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
IGM Biosciences (IGMS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksIGM Biosciences (IGMS) Upgraded to Buy: What Does It Mean for the Stock?
IGM Biosciences (IGMS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ZacksIGM Biosciences, Inc. (IGMS) Reports Q4 Loss, Lags Revenue Estimates
IGM Biosciences, Inc. (IGMS) delivered earnings and revenue surprises of 4.72% and 31.47%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
